Diabetes and Metabolic Diseases: From Prevention to Clinical Management

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 94

Special Issue Editors


E-Mail Website
Guest Editor
Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Italy
Interests: type 2 diabetes; obesity; gut microbiome; metabolic dysfunction-associated steatotic liver disease (MASLD)

E-Mail Website
Guest Editor
Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Italy
Interests: obesity; autoimmune diabetes; MASLD; type 2 diabetes

Special Issue Information

Dear Colleagues,

This Special Issue, entitled "Diabetes and Metabolic Diseases: From Prevention to Clinical Management", aims to thoroughly explore the complex landscape of diabetes and metabolic disorders. It sheds light on key aspects, ranging from preventive measures to therapeutic solutions. Given the intertwined nature of obesity and diabetes, both of which are escalating to pandemic levels, there is an urgent call for comprehensive approaches that cover prevention, early detection, and targeted treatments.

Prevention strategies take the forefront, recognizing the pivotal role of lifestyle changes like dietary adjustments and increased physical activity in halting the progression of these disorders. Early detection plays a crucial role in intervening promptly in order to slow down disease advancement and prevent complications. The issue delves into screening methods and diagnostic tools which can enable the early identification of individuals at risk.

Therapeutic options are varied and tailored to suit each patient's unique needs, considering the diverse nature of diabetes and metabolic diseases. From dietary manipulations like nutritional ketosis to medications targeting feeding behavior and the incretin system, the importance of personalized treatment approaches is underscored.

Furthermore, the issue emphasizes the significance of holistic management strategies. This includes integrating pharmacotherapy with lifestyle adjustments, patient education, and psychosocial support in order to optimize outcomes and improve the quality of life for those dealing with type 2 diabetes and obesity.

Dr. Davide Masi
Dr. Renata Risi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • obesity
  • nutritional ketosis
  • dietary manipulations
  • therapeutic inertia
  • type 2 diabetes
  • gut microbiome
  • incretins
  • hormone regulation

Published Papers

This special issue is now open for submission.
Back to TopTop